Classes
- ???????D01000148 | Second Faculty of Medicine
- Clinical MicrobiologyD0100038 | Second Faculty of Medicine
- Molecular microbiologyD0100266 | Second Faculty of Medicine
- Medical Microbiology I +3D0104338 | Second Faculty of Medicine
- Medical Microbiology II +2D0105038 | Second Faculty of Medicine
- Clinical 10 days - Department of Medical MicrobiologyD0110MIK | Second Faculty of Medicine
- MicrobiologyD0804010 | Second Faculty of Medicine
- Microbiology and immunology +1D0904001 | Second Faculty of Medicine
- Microbiology I. +1D1104339 | Second Faculty of Medicine
- Microbiology II. +1D1105038 | Second Faculty of Medicine
Publications
- Role of Novel Microbiological Diagnostics in the Care for Patients with Cystic Fibrosis2008 | Second Faculty of Medicine
- Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues2024 | Central Library of Charles University, Second Faculty of Medicine
- Standards for the care of people with cystic fibrosis; establishing and maintaining health2024 | Second Faculty of Medicine
- Quality of MALDI-TOF Mass Spectra in Routine Diagnostics: Results from an International External Quality Assessment including 36 Laboratories from 12 countries using 47 challenging bacterial strains2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Pulmonary tularaemia in a female adolescent with inflammatory bowel disease receiving infliximab: Do not miss the diagnosis2023 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- To screen or not to screen medical students for carriage of multidrug-resistant pathogens?2023 | Faculty of Science, Second Faculty of Medicine
- Clinical outcomes associated with Achromobacter species infection in people with cystic fibrosis2023 | Second Faculty of Medicine
- Clostridioides difficile infections were predominantly driven by fluoroquinolone-resistant Clostridioides difficile ribotypes 176 and 001 in Slovakia in 2018-20192023 | Second Faculty of Medicine
- Characteristics of the ID-NOWTM test for the rapid detection of SARS-CoV-22023 | Second Faculty of Medicine
- Elexacaftor-tezacaftor-ivacaftor in patients with cystic fibrosis ineligible for clinical trials: a 24-week observational study2023 | Second Faculty of Medicine
Loading network view...